Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–21. https://doi.org/10.1038/s41423-020-0488-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haslam A, Prasad V. Estimation of the percentage of US Patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open. 2019;2(5):e192535. https://doi.org/10.1001/jamanetworkopen.2019.2535.

Article  PubMed  PubMed Central  Google Scholar 

Oladejo M, Paulishak W, Wood L. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines. Semin Cancer Biol. 2023;88:81–95. https://doi.org/10.1016/j.semcancer.2022.12.003.

Article  CAS  PubMed  Google Scholar 

Lin MJ, Svensson-Arvelund J, Lubitz GS, et al. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3(8):911–26. https://doi.org/10.1038/s43018-022-00418-6.

Article  CAS  PubMed  Google Scholar 

Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360–78. https://doi.org/10.1038/s41568-021-00346-0.

Article  CAS  PubMed  Google Scholar 

Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: Building a bridge over troubled waters. Cell. 2022;185(15):2770–88. https://doi.org/10.1016/j.cell.2022.06.035.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pounraj S, Chen S, Ma L, Mazzieri R, Dolcetti R, Rehm BHA. Targeting tumor heterogeneity with neoantigen-based cancer vaccines. Can Res. 2024;84(3):353–63. https://doi.org/10.1158/0008-5472.Can-23-2042.

Article  CAS  Google Scholar 

Ghattas M, Dwivedi G, Lavertu M, Alameh MG. Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines. 2021. https://doi.org/10.3390/vaccines9121490.

Article  PubMed  PubMed Central  Google Scholar 

Tashiro H, Brenner MK. Immunotherapy against cancer-related viruses. Cell Res. 2017;27(1):59–73. https://doi.org/10.1038/cr.2016.153.

Article  CAS  PubMed  Google Scholar 

Lei J, Ploner A, Elfström KM, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–8. https://doi.org/10.1056/NEJMoa1917338.

Article  CAS  PubMed  Google Scholar 

Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA. The importance of immunization in cancer prevention, treatment, and survivorship. CA Cancer J Clin. 2017;67(5):398–410. https://doi.org/10.3322/caac.21407.

Article  PubMed  Google Scholar 

DeMaria PJ, Bilusic M. Cancer vaccines. Hematol Oncol Clin North Am. 2019;33(2):199–214. https://doi.org/10.1016/j.hoc.2018.12.001.

Article  PubMed  Google Scholar 

Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81–94. https://doi.org/10.1038/nrclinonc.2017.166.

Article  CAS  PubMed  Google Scholar 

Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev Disease Prim. 2019;5(1):66. https://doi.org/10.1038/s41572-019-0111-2.

Article  Google Scholar 

Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124–8. https://doi.org/10.1126/science.aaa1348.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Allen EM, Miao D, Schilling B, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015;350(6257):207–11. https://doi.org/10.1126/science.aad0095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med. 2017;377(25):2500–1. https://doi.org/10.1056/NEJMc1713444.

Article  PubMed  PubMed Central  Google Scholar 

Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15(17):5323–37. https://doi.org/10.1158/1078-0432.Ccr-09-0737.

Article  Google Scholar 

Leko V, Rosenberg SA. Identifying and targeting human tumor antigens for t cell-based immunotherapy of solid tumors. Cancer Cell. 2020;38(4):454–72. https://doi.org/10.1016/j.ccell.2020.07.013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pedersen SR, Sørensen MR, Buus S, Christensen JP, Thomsen AR. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy. J Immunol. 2013;191(7):3955–67. https://doi.org/10.4049/jimmunol.1300555.

Article  CAS  PubMed  Google Scholar 

Parkhurst MR, Yang JC, Langan RC, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther J Am Soc Gene Ther. 2011;19(3):620–6. https://doi.org/10.1038/mt.2010.272.

Article  CAS  Google Scholar 

Jou J, Harrington KJ, Zocca MB, Ehrnrooth E, Cohen EEW. The changing landscape of therapeutic cancer vaccines-novel platforms and neoantigen identification. Clin Cancer Res Off J Am Assoc Cancer Res. 2021;27(3):689–703. https://doi.org/10.1158/1078-0432.Ccr-20-0245.

Article  CAS  Google Scholar 

Smith CC, Selitsky SR, Chai S, Armistead PM, Vincent BG, Serody JS. Alternative tumour-specific antigens. Nat Rev Cancer. 2019;19(8):465–78. https://doi.org/10.1038/s41568-019-0162-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lybaert L, Lefever S, Fant B, et al. Challenges in neoantigen-directed therapeutics. Cancer Cell. 2023;41(1):15–40. https://doi.org/10.1016/j.ccell.2022.10.013.

Article  CAS  PubMed  Google Scholar 

Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L. Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther. 2023;8(1):9. https://doi.org/10.1038/s41392-022-01270-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tran NH, Qiao R, Xin L, Chen X, Shan B, Li M. Personalized deep learning of individual immunopeptidomes to identify neoantigens for cancer vaccines. Nat Mach Intell. 2020;2(12):764–71. https://doi.org/10.1038/s42256-020-00260-4.

Article  Google Scholar 

van Buuren MM, Calis JJ, Schumacher TN. High sensitivity of cancer exome-based CD8 T cell neo-antigen identification. Oncoimmunology. 2014;3:e28836. https://doi.org/10.4161/onci.28836.

Article  PubMed  PubMed Central  Google Scholar 

Thind AS, Monga I, Thakur PK, et al. Demystifying emerging bulk RNA-Seq applications: the application and utility of bioinformatic methodology. Brief Bioinform. 2021. https://doi.org/10.1093/bib/bbab259.

Article  PubMed